R Squared’s RxSight RXST Stock Holding History

R Squared’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-90	Closed	-$3.09K	–	1255
2024 Q4	$3.09K	Buy	+90	New	+$4.06K	﹤0.01%	1406

Other funds holding RXST

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

R Squared's RXST Position: Q1 2025 in Review

R Squared sold out of RxSight (RXST) in Q1 2025, closing a stake of 90 shares — an estimated $3.09K sold.

R Squared first reported a position in RXST in Q4 2024 and held it in 1 quarter. The position peaked at $3.09K in Q4 2024. 192 funds tracked by Wall St. Rank hold RXST as of Q1 2025.

R Squared reported no remaining RxSight position as of Q1 2025 after selling out during the quarter.
R Squared sold 90 RxSight shares in Q1 2025, an estimated $3.09K.
R Squared first reported a position in RxSight in Q4 2024 and held it in 1 quarter.
R Squared's RxSight position peaked at $3.09K in Q4 2024.
192 funds tracked by Wall St. Rank held RxSight as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.